Detalhe da pesquisa
1.
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma.
N Engl J Med
; 389(2): 148-157, 2023 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272527
2.
Real-World and Clinical Trial Outcomes in Large B-cell Lymphoma with Axicabtagene Ciloleucel Across Race and Ethnicity.
Blood
; 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38635762
3.
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma.
N Engl J Med
; 386(7): 640-654, 2022 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34891224
4.
Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents.
Blood
; 141(22): 2727-2737, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36857637
5.
Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma.
Blood
; 141(19): 2307-2315, 2023 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36821768
6.
Management of post-autologous transplant relapse in patients with T-cell lymphomas.
Am J Hematol
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38661220
7.
Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B-cell lymphoma after 2 or more lines of prior therapy.
Am J Hematol
; 99(5): 880-889, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38504387
8.
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma.
N Engl J Med
; 382(14): 1331-1342, 2020 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32242358
9.
Detection of Aberrant CD58 Expression in a Wide Spectrum of Lymphoma Subtypes: Implications for Treatment Resistance.
Mod Pathol
; 36(10): 100256, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37391168
10.
CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR-refractory large B-cell lymphoma.
Blood
; 137(17): 2321-2325, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512414
11.
Outcomes with Autologous or Allogeneic Stem Cell Transplantation in Patients with Plasma Cell Leukemia in the Era of Novel Agents.
Biol Blood Marrow Transplant
; 26(12): e328-e332, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32961371
12.
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.
N Engl J Med
; 377(26): 2531-2544, 2017 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29226797
13.
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial.
Lancet Oncol
; 20(1): 31-42, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30518502
14.
Targeting PI3Kδ function for amelioration of murine chronic graft-versus-host disease.
Am J Transplant
; 19(6): 1820-1830, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30748099
15.
Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease.
Biol Blood Marrow Transplant
; 24(2): 373-380, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29051021
16.
Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT.
Blood
; 128(25): 2899-2908, 2016 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27802969
17.
CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel.
Blood
; 138(12): 1081-1085, 2021 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34041526
18.
Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel therapy.
Blood
; 137(13): 1832-1835, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33156925
19.
The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 23(2): 211-234, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27713092
20.
Outcomes of older patients in ZUMA-1, a pivotal study of axicabtagene ciloleucel in refractory large B-cell lymphoma.
Blood
; 135(23): 2106-2109, 2020 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32181801